Our Latest News
and actionable tips.
Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs
Cartography Biosciences Expands Leadership Team with Appointment of Dan Rock, Ph.D., as Chief Scientific Officer to Advance Novel Oncology Programs into Clinic
— Dr. Rock to support Cartography in the translation of tumor-specific targets into therapeutics, with initial focus on its lead program for colorectal cancer (CRC) — SOUTH SAN FRANCISCO, February 7, 2024 Cartography Biosciences, an oncology company advancing a...
Cartography Biosciences and Nested Therapeutics: Diamonds in the rough
Cartography Biosciences Expands Scientific Advisory Board with Leading Antibody and Bi-specific Experts
—Newly appointed members Tara Arvedson, Ph.D., and Janine Schuurman, Ph.D., to support Cartography in the advancement of first-in-class precision cancer immunotherapies— May 31, 2023 08:00 AM Eastern Daylight Time SOUTH SAN FRANCISCO--(BUSINESS WIRE)--Cartography...
Cartography Biosciences Co-Founder and Chief Executive Officer Kevin Parker, Ph.D., Earns Spot on Endpoints News’ 20 Under 40 List
—Annual list spotlights the young biopharma leaders making their mark on the industry— SOUTH SAN FRANCISCO, May 30, 2023 – Cartography Biosciences, an immuno-oncology company creating biologic therapies against novel targets guided by the first-ever comprehensive...
Cartography Biosciences Appoints Industry Veteran as Chief Administrative and Legal Officer
—Blaine Templeman will support the team’s mission to develop more precise and effective cancer immunotherapies for patients— May 25, 2023 08:00 AM Eastern Daylight Time SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cartography Biosciences, an immuno-oncology company...